Acute Myeloid Leukemia (AML)

Understanding Clinical Trials

This guide provides information about clinical trials and gives you some things to consider when deciding whether to take part

What is Biosimilar?

A Biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication)

Financial Resources

A list of organizations & programs that may provide financial resources & other assistance

ASH 2019 (MDS/AML)

MDS and AML Research Summaries for Patients from the 2019 American Society of Hematology Annual Meeting

ASH 2018 (MDS/AML)

MDS and AML Research Summaries for Patience from the 2018 American Society of Hematology Annual Meeting

EHA/ASCO 2019

Research Summaries for Patients from the 2019 European Hematology Association and the 2019 American Society of Clinical Oncology meetings

ASH 2020

Bone Marrow Failure Disease Research Summaries for Patients from the 2020 American Hematology Society Annual Meeting

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.